The Federal Government Now Holds the Original 1994 Ibogaine Research Application
The University of Miami handed its original 1994 ibogaine Investigational New Drug application over to HHS Secretary Robert F. Kennedy Jr., which President Trump framed as accelerating ibogaine's path toward federal research and, eventually, veteran access. An IND is the foundational filing that lets researchers legally study a drug in humans — a three-decade-old one on file could shortcut groundwork any new ibogaine program would otherwise have to redo from scratch. It's the latest follow-through on Trump's April executive order directing $50 million toward psychedelic research: the VA now runs more than 20 active psychedelic-related studies, and VA and HHS signed a cooperation MOU on this exact area back in July. Ibogaine itself remains Schedule I and unapproved for any use.
Read at Newsweek